InvestorsHub Logo
Followers 89
Posts 7109
Boards Moderated 0
Alias Born 09/18/2009

Re: None

Saturday, 05/03/2025 7:06:10 PM

Saturday, May 03, 2025 7:06:10 PM

Post# of 43970
In previous posts, I mentioned,

"Jay Booth
@booth37337
·
Apr 27
I will be disappointed if the new NIH covid treatment guideline does not just simply recommend the single Approved (lenz-enhanced?) Novavax covid vaccine. Further, since this is a real vaccine, in the traditional sense of the word, and since lenz is variant-agnostic, I don't

Jay Booth
@booth37337
·
Apr 27
think we need to signify "covid years" going forward. At least, this represents my expectation of these gentlemen, and my belief in their desire and ability to make this happen."



I noted also that this one-and-done approach should apply to Sanofi's Covid-Influenza-Combination (CIC) vaccine.

Hold that thought.

A few hours ago, I saw this article.

"HHS touts universal flu, coronavirus vaccine initiative while casting doubt on future of seasonal Covid-19 shots
Meg Tirrell and Brenda Goodman, CNN
Thu, May 1, 2025

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat that hasn’t been achieved for the past 45: the development of a universal flu vaccine that could protect against multiple virus strains with pandemic potential, including H5N1 avian influenza.

“Generation Gold Standard is a paradigm shift,” National Institutes of Health Director Dr. Jay Bhattacharya said in a statement on the new initiative. “It extends vaccine protection beyond strain-specific limits and prepares for flu viral threats – not just today’s, but tomorrow’s as well – using traditional vaccine technology brought into the 21st century.”

HHS said the project, being developed in-house at the National Institute of Allergy and Infectious Diseases, is targeting US Food and Drug Administration approval of universal influenza vaccines in 2029, with human clinical trials scheduled to start next year. The Wall Street Journal first reported that it will be funded with $500 million from the Biomedical Advanced Research and Development Authority, a figure confirmed by a spokesperson for HHS...

A similar paradigm has unfolded for Covid-19 vaccines since they were first authorized in the height of the pandemic at the end of 2020. HHS’s new initiative also aims to develop universal coronavirus vaccines that could provide protection against not just the virus that causes Covid-19 – SARS-CoV-2 – but its cousins SARS-CoV-1 and MERS-CoV.

A large investment in older technology
The vaccine technology in HHS’s new initiative uses inactivated whole-virus vaccines, an older approach that delivers an entire virus that’s been chemically tweaked so it can’t infect human cells. The project comes from work being driven by Dr. Matthew Memoli, the NIH’s principal deputy director, and Dr. Jeffery Taubenberger, acting director of NIAID."

https://www.yahoo.com/news/hhs-touts-universal-flu-coronavirus-210630297.html

It may be worth noting that before Bobby fired her, Fauci's wife was, "...a top bioethicist at the National Institutes of Health..."

https://www.allsides.com/news/2025-04-03-0819/public-health-fauci-s-wife-nih-bioethicist-who-never-probed-ethics-wuhan

So maybe I wasn't too far off the mark, and it may really be possible for the triumvirate of Humanigen/Novavax/Sanofi to own the covid AND flu markets with the only FDA-Approved vaccines.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.